Tenet Healthcare Corporation (THC) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Conference Call February 12, 2025 10:00 AM ETCompany ParticipantsWill McDowell - Vice President ...
What a $2 Million Per Dose Gene Therapy Reveals About Drug Pricing
Robin Fields ProPublica is a nonprofit newsroom that investigates abuses of power. Sign up to receive our biggest stories as ...
Medical Design and Outsourcing6h
Tanaka launches Visi Fine precious metal materials for medical device components
The Tanaka Precious Metal Technologies Visi Fine series includes platinum alloy wire and other highly radiopaque precious ...
Business Wire7h
Access Vascular Catheters with MIMIX® Technology Added to Recon Supply’s Federal Supply Schedule Contract
Access Vascular, Inc. (AVI), a leader in tackling critical vascular access challenges with its advanced hydrophilic biomaterial technology, today anno ...
New device helps people with spinal cord injuries grasp large, heavy objects
More than 15 million people worldwide are living with spinal cord injury (SCI), which can affect their sensory and motor ...
Earnings call transcript: Tenet Healthcare misses Q4 2024 revenue forecast
Tenet Healthcare Corporation (NYSE:THC) reported its fourth-quarter 2024 earnings, revealing a mixed performance that saw ...